H Christian Eberl

10PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsPharmacogenomicsMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 17, 2026
Identification of novel drug-specific PARP inhibitor resistance mechanisms in ovarian cancer-implications for clinical practice.

|Aug 13, 2024
Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and Safety.

Joseph E Pero, Elizabeth A Mueller, Ashley M Adams

|Jul 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation.

Anna Rutkowska, H Christian Eberl, Thilo Werner

|Apr 08, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells.

Gabriele Picco, Yanhua Rao, Angham Al Saedi

|Nov 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.

Melissa B Pappalardi, Kathryn Keenan, Mark Cockerill

|Jul 08, 2021
IFN-γ Drives Human Monocyte Differentiation into Highly Proinflammatory Macrophages That Resemble a Phenotype Relevant to Psoriasis.

Rosario Luque-Martin, Davina C Angell, Mathias Kalxdorf

Pageof 2

Frequent Collaborators

6 joint publications

Marcus Bantscheff

2 joint publications

Jacob T Bush

2 joint publications

Geeta Sharma

2 joint publications

Anna Rutkowska-Klute